• 圣淘沙名胜世界(新加坡)

    Neural differentiation of AAVS1-TRE3G-NGN2 pluripotent stem cells

    Jiuchun Zhang, Harper JW

    Published: 2021-08-13 DOI: 10.17504/protocols.io.br9em93e
    AI 解读
    浏览 1257

    Abstract

    This protocol is about neural differentiation of AAVS1-TRE3G-NGN2 pluripotent stem cells.

    Before start

    Prepare ND1 Medium and ND2 Medium:

    ND1 Medium

    DMEM/F12

    N2 (100x) 1x

    BDNF 10 ng/ml

    NT3 10 ng/ml

    NEAA (100X) 1x

    Laminin 0.2 μg/ml

    Doxycycline 2 μg/ml

    ND2 Medium

    Neurobasal medium

    B27 (50x) 1x

    Glutamax (100x) 1x

    BDNF 10 ng/ml

    NT3 10 ng/ml

    Doxycycline 2 μg/ml

    Note
    * Doxycycline can be withdrawn on Day 10 (or even earlier-not tested yet).* Cells can be split from Day 5 to Day 7 (or even earlier-not tested yet).

    Attachments

    Neural_differentiation_of_AAVS1-TRE3G-NGN2-pluripotent_stem_cells.pdf

    Steps

    Day 0:

    1.

    Treat H9 AAVS1-TRE3G-NGN2 cells with Accutase and plate the dissociated cells in matrigel-coated 6-well plates (2x105 cells/well) in ND1 Medium supplemented with Y27632 (10micromolar (µM)).

    Day 1:

    2.

    Replace the medium with ND1 Medium .

    Day 2:

    3.

    Replace the medium with ND2 Medium .

    Day 4:

    4.

    Exchange 50% of the medium from each well.

    Day 6:

    5.

    Treat the cells with Accutase and replate the dissociated cells in matrigel-coated 6-well plates (2-4x105 cells/well) in ND2 Medium .

    Day 8 and thereafter:

    6.

    Exchange 50% of the medium from each well every other day.

    Note
    * Doxycycline can be withdrawn on Day 10 (or even earlier-not tested yet).* Cells can be split from Day 5 to Day 7 (or even earlier-not tested yet).

    推荐阅读

    Nature Protocols
    Protocols IO
    Current Protocols
    扫码咨询